Neurochemical characteristics of the ventromedial hypothalamus in mediating the antiaversive effects of anxiolytics in different models of anxiety

Neuroscience and Behavioral Physiology

Volumn 33, Issue 3, 2003, Pages 255-261

  Talalaenko, A N ^a   Pankrat'ev, D V ^a   Goncharenko, N V ^a  

^a DONETSK MEDICAL UNIVERSITY   (Ukraine)

Author keywords

Anxiety; Anxiolytics; Hypothalamus; Neurochemical mechanisms

Indexed keywords

4 AMINO 3 PHENYLBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; AMINO ACID; ANXIOLYTIC AGENT; APOMORPHINE; ARCAINE; BENZODIAZEPINE DERIVATIVE; CHLORDIAZEPOXIDE; CLONIDINE; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DROPERIDOL; HARMAN; INDOTER; KAMPIRONE; MEMANTINE; MONOAMINE DERIVATIVE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROTRANSMITTER; PENTETRAZOLE; PHENTOLAMINE; PHENYLEPHRINE; PICROTOXIN; PROPRANOLOL; SEROTONIN 1A ANTAGONIST; SEROTONIN 1B ANTAGONIST; SULPIRIDE; UNINDEXED DRUG; YOHIMBINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ANXIETY DISORDER; ARTICLE; AVERSIVE BEHAVIOR; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG MEGADOSE; FEAR; GABAERGIC SYSTEM; LIMBIC SYSTEM; MALE; MICROINJECTION; MOTIVATION; NEUROCHEMISTRY; NONHUMAN; RAT; SEROTONINERGIC SYSTEM; STRESS; SYNAPTIC TRANSMISSION; ZONA INCERTA;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; ANTI-ANXIETY AGENTS; ANTICONVULSANTS; ANXIETY; APOMORPHINE; AVOIDANCE LEARNING; BIGUANIDES; BRAIN CHEMISTRY; CHLORDIAZEPOXIDE; CLONIDINE; DISEASE MODELS, ANIMAL; DOPAMINE; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DROPERIDOL; DRUG INTERACTIONS; GABA AGENTS; GABA ANTAGONISTS; GABA MODULATORS; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; MALE; MEMANTINE; MEPHENYTOIN; MICROINJECTIONS; PENTYLENETETRAZOLE; PHENTOLAMINE; PICROTOXIN; PIPERAZINES; PROPRANOLOL; PYRIMIDINES; RATS; SEROTONIN; SULPIRIDE; VENTROMEDIAL HYPOTHALAMIC NUCLEUS; YOHIMBINE;

EID: 0038079329     PISSN: 00970549     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022151331354     Document Type: Article

References (18)

1. Ya. Buresh, M. Petran', and I. Zakhar, Electrophysiological Methods in Research [in Russian], Nauka, Moscow (1962).
2. V. E. Gmiro and S. E. Sendyuk, "Bis-ammonium adamantane-containing compounds - New modulators of the polyamine binding site," Éksperim. Klin. Farmakol., 63, No. 3, 16-20 (2000).
3. A. N. Talalaenko, D. V. Gordienko, and O. P. Markova, "Studies of monoamine- and aminoacidergic mechanisms of the caudate nucleus in rats in producing the antiaversive effects of tranquillizers in different models of anxiety," Ros. Fiziol. Zh. im. I. M. Sechenova, 85, No. 8, 1043-1050 (1999).
4. B. Cole and T. Robbins, "Dissociable effects of lesions to the dorsal or ventral noradrenergic bundle on the acquisition, performance, and extinction of aversive conditioning," Behav. Neurosci., 101, No. 4, 476-488 (1987).
5. 1A receptors under psychosocial stress," J. Neurosci., 15, No. 11, 7132-7140 (1995).
6. G. Graeff, "Neuroanatomy and neurotransmitter regulation of defensive behaviors and related emotions in mammals," Braz. J. Med. Biol. Res., 27, No. 4, 1997-1088 (1994).
7. M. Koprowska, M. Krotewska, A. Romanuk, M. Strzelczuk, and M. Wieczorek, "Behavioral and neurochemical alterations evoked by people-chlorphenylalanine application in rats examined in the light-dark crossing test," Acta Neurobiol. Exp., 59, No. 1, 15-22 (1999).
8. M. Kruk, A. Van der Poel, and W. Meelis, "Drugs and stimulation-evoked hypothalamic aggression and related responses in the rat," Psychopharmacology, 96, No. 1, 33-42 (1988).
9. H. Meede, S. Meki, and H. Uchimura, "Facilitatory effects of caerulin on hypothalamic defensive attack in cats," Brain Res., 459, No. 2, 351-355 (1988).
10. J. Martin, E. Edwards, J. Johnson, and F. Henn, "Monoamine receptors in an animal model of affective disorder," J. Neurochem., 55, No. 4, 1142-1148 (1990).
11. M. Mlani and F. Graeff, "GABA-benzodiazepine modulation of aversion in the medial hypothalamus of the rat," Pharmacol. Biochem. Behav., 28, No. 21-22, 21-27 (1987).
12. M. Nazar, M. Siematkowski, A. Czlonkowska, and A. Plaznik, "The role of hippocampus in the interaction between GABA and 5-HT system in anxiety control in rats," Pol. J. Pharmacol., 49, No. 2-3, 162 (1997).
13. 1A receptors in the anticonflict activity of β-adrenergic antagonists," Pol. J. Pharmacol., 47, No. 1, 22 (1995).
14. T. Sajdyk, J. Katner, and A. Shekhar, "Monoamines in the dorsomedial hypothalamus of rats following exposure to different tests of 'anxiety'," Progr. Neuropsychopharmacol. Biol. Psychiatr., 21, No. 1, 193-209 (1997).
15. A. Shekhar, J. Hingtgen, and J. Di Micco, "GABA receptors in the posterior hypothalamus regulate experimental anxiety in rats," Brain Res., 512, No. 1, 81-88 (1990).
16. A. Shekhar and J. Katner, "Dorsomedial hypothalamic GABA regulates anxiety in the social interaction test," Pharmacol. Biochem. Behav., 50, No. 2, 253-258 (1995).
17. A. Valjakka, P. Riekkinen, J. Sirvio, S. Nieminen, M. Airaksinen, and R. Mauno, "The effects of dorsal noradrenergic bundle lesions on spatial learning locomotor activity and reaction to novelty," Behav. Neural. Biol., 54, No. 3, 323-329 (1990).
18. H. Yokoo, M. Tanaka, A. Tsuda, T. Tanaka, and K. Mizoguchi, "Direct evidence of conditioned fear-elicit enhancement of noradrenaline release in the rat hypothalamus assessed by intracranial microdialysis," Brain Res., 536, No. 1-2, 305-308 (1990).